semaglutide cardiovascular risk 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the of CV death/MI/stroke regardless of baseline CKD severity in participants Wegovy will be available for

[00:28:40] Emily Field: Because if we just want this whole episode talking about why muscle matters, why training matters, and why preserving strength matters, then we also have to acknowledge this

Alpha lipoic acid (ALA) is an antioxidant that functions in every cell of your body since its both water and fat-soluble

The Safety Profile of Sustained Release Paracetamol During Therapeutic Use and Following Overdose

reported in a propensity score-matched population-based cohort analysis that GLP-1 receptor agonist use in patients with MASLD and type 2 diabetes was associated with a lower risk of HCC (aHR: 0.55, 95%CI: 0.44-0.69) and all-cause mortality (aHR: 0.62, 95%CI: 0.55-0.71) [59]

NAC MAX is a powerful antioxidant blend that optimizes glutathione production